Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05997615 |
Title | Safety, Pharmacokinetics, and Preliminary Efficacy of AMX-500 in Metastatic Castration Resistant Prostate Cancer (mCRPC) |
Recruitment | Recruiting |
Gender | male |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Amunix, a Sanofi Company |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | GBR | ESP | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Investigational Site Number: 101 | RECRUITING | New South Wales | 2010 | Australia | Details | |
Investigational Site Number: 100 | RECRUITING | Victoria | 3000 | Australia | Details | |
Investigational Site Number: 251 | RECRUITING | Barcelona | 08023 | Spain | Details | |
Investigational Site Number: 250 | RECRUITING | Barcelona | 08035 | Spain | Details | |
Investigational Site Number: 254 | RECRUITING | Madrid | 28027 | Spain | Details | |
Investigational Site Number: 252 | RECRUITING | Madrid | 28223 | Spain | Details | |
Investigational Site Number: 253 | RECRUITING | Pamplona | 31008 | Spain | Details | |
Investigational Site Number: 300 | RECRUITING | London | SM2 5PT | United Kingdom | Details |